Outcomes of acute ischemic stroke and reperfusion therapy in patients with Moyamoya disease

Moyamoya disease (MMD) is an uncommon cerebrovascular condition associated with acute ischemic stroke (AIS) and intracranial hemorrhage. This study examines outcomes of AIS in patients with MMD (MMD-AIS) and associated outcomes of endovascular thrombectomy (EVT) and intravascular thrombolysis (IVT). This retrospective cross-sectional analysis used the National Inpatient Sample database (2015–2022), including adult (≥18 years-old) U.S. hospitalizations for AIS with reported NIH Stroke Scale (NIHSS). Inverse probability of treatment weighting adjusted for confounding factors. Multivariable logistic regression estimated adjusted odds ratios (aORs) and 95% confidence intervals (CIs). Among 1,733,390 AIS hospitalizations, 3,735 (0.2%) involved comorbid MMD; 150 (4.0%) underwent EVT while 300 (8.0%) received IVT. MMD was associated with reduced use of EVT (aOR: 0.362, 95% CI [0.238–0.553], p < 0.001) and IVT (0.315 [0.242–0.412], p < 0.001) compared with non-MMD AIS. Following IPTW, MMD was associated with similar inpatient mortality (1.29 [0.797–2.09], p = 0.299), reduced routine discharge (0.639 [0.540–0.757], p < 0.001), and similar hemorrhagic transformation (1.13 [0.742–1.74], p = 0.560). Among the MMD-AIS group with NIHSS > 5, EVT was not associated with differences in routine discharge (0.672 [0.398–1.14], p = 0.137), inpatient mortality (0.072 [0.004–1.20], p = 0.067), or hemorrhagic transformation (1.61 [0.896–2.88], p = 0.111). IVT was associated with increased routine discharge (1.96 [1.35–2.85], p < 0.001), and no difference in hemorrhagic transformation (0.948 [0.542–1.66], p = 0.852) or mortality (1.74 [0.811–3.75], p = 0.155). MMD-AIS was associated with reduced routine discharge without increased hemorrhagic risk. EVT and IVT were infrequently used but may be feasible in selected patients. Prospective studies are needed to determine the efficacy of reperfusion therapy in this population.

Authors

Publication Details

Journal
Figshare
Published
2026-11-14
DOI
https://doi.org/10.6084/m9.figshare.35010205
Primary Topic
Moyamoya disease diagnosis and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Outcomes of acute ischemic stroke and reperfusion therapy in patients with Moyamoya disease

Sauson Soldozy, Aryan Malhotra, Eilene Basu, Ariel Sacknovitz et al.
Figshare
Moyamoya disease diagnosis and treatment
article

Outcomes of acute ischemic stroke and reperfusion therapy in patients with Moyamoya disease

Sauson Soldozy, Aryan Malhotra, Eilene Basu, Ariel Sacknovitz, Isaac B. Thorman, Aarti Kishore Jain, Nimrod Gozum, James M. Beck, Fawaz Al-Mufti, Eric Feldstein, Shayna Kar, Chirag D. Gandhi, Gurmeen Kaur
article en

Abstract

Moyamoya disease (MMD) is an uncommon cerebrovascular condition associated with acute ischemic stroke (AIS) and intracranial hemorrhage. This study examines outcomes of AIS in patients with MMD (MMD-AIS) and associated outcomes of endovascular thrombectomy (EVT) and intravascular thrombolysis (IVT). This retrospective cross-sectional analysis used the National Inpatient Sample database (2015–2022), including adult (≥18 years-old) U.S. hospitalizations for AIS with reported NIH Stroke Scale (NIHSS). Inverse probability of treatment weighting adjusted for confounding factors. Multivariable logistic regression estimated adjusted odds ratios (aORs) and 95% confidence intervals (CIs). Among 1,733,390 AIS hospitalizations, 3,735 (0.2%) involved comorbid MMD; 150 (4.0%) underwent EVT while 300 (8.0%) received IVT. MMD was associated with reduced use of EVT (aOR: 0.362, 95% CI [0.238–0.553], p < 0.001) and IVT (0.315 [0.242–0.412], p < 0.001) compared with non-MMD AIS. Following IPTW, MMD was associated with similar inpatient mortality (1.29 [0.797–2.09], p = 0.299), reduced routine discharge (0.639 [0.540–0.757], p < 0.001), and similar hemorrhagic transformation (1.13 [0.742–1.74], p = 0.560). Among the MMD-AIS group with NIHSS > 5, EVT was not associated with differences in routine discharge (0.672 [0.398–1.14], p = 0.137), inpatient mortality (0.072 [0.004–1.20], p = 0.067), or hemorrhagic transformation (1.61 [0.896–2.88], p = 0.111). IVT was associated with increased routine discharge (1.96 [1.35–2.85], p < 0.001), and no difference in hemorrhagic transformation (0.948 [0.542–1.66], p = 0.852) or mortality (1.74 [0.811–3.75], p = 0.155). MMD-AIS was associated with reduced routine discharge without increased hemorrhagic risk. EVT and IVT were infrequently used but may be feasible in selected patients. Prospective studies are needed to determine the efficacy of reperfusion therapy in this population.

Figshare
Moyamoya disease diagnosis and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon